↓ Skip to main content

Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America

Overview of attention for article published in Neurology and Therapy, May 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
58 Mendeley
Title
Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
Published in
Neurology and Therapy, May 2019
DOI 10.1007/s40120-019-0139-y
Pubmed ID
Authors

Judith Steinberg, Yara D. Fragoso, Juan Carlos Duran Quiroz, Juan Raul García, Caroline Guerra, Virginia Rodriguez, Claudia Carcamo Rodriguez, Ethel Ciampi, Edgar Correa-Diaz, Miguel Macías, Nelson Novarro, Darwin Vizcarra, Carlos Oehninger Gatti, Geraldine Orozco, Adriana Carrá

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 14%
Researcher 8 14%
Other 7 12%
Student > Bachelor 6 10%
Lecturer 3 5%
Other 7 12%
Unknown 19 33%
Readers by discipline Count As %
Medicine and Dentistry 10 17%
Neuroscience 7 12%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Business, Management and Accounting 3 5%
Immunology and Microbiology 2 3%
Other 8 14%
Unknown 22 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 June 2019.
All research outputs
#15,574,539
of 23,149,216 outputs
Outputs from Neurology and Therapy
#273
of 429 outputs
Outputs of similar age
#215,572
of 349,958 outputs
Outputs of similar age from Neurology and Therapy
#5
of 9 outputs
Altmetric has tracked 23,149,216 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 429 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,958 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.